Li et al. provided that FTO promotes non-small cell lung cancer (NSCLC)25 and breast tumor progressions through increasing the expression of USP726 as well as inhibiting BNIP327 respectively. The gene discussed is FTO; the disease is non-small cell lung carcinoma.